DBV Technologies (DBVT NASDAQ) stock market data APIs
$19.6555
0.18(0.9%)
as of May 13, 2026
Try our APIs with
free plan!
DBV Technologies Financial Data Overview
Price chart is built with
Anychart
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Prev. Close
19.6555
Open
19.8348
High
20.0495
Low
19.2075
52 wk Range
7.526-26.185
Market Cap
1 205 M
Shares Outstanding
59 183 K
Revenue
5 736 K
EPS
-0.0938
Beta
-0.236
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DBV Technologies data using free add-ons & libraries
Get DBV Technologies Fundamental Data
DBV Technologies Fundamental data includes:
- Net Revenue: 5 736 K
- EBITDA: -165 162 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-01
- EPS/Forecast: -0.121
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DBV Technologies News
New
DBV Technologies Reports First Quarter 2026 Financial Results
Châtillon, France, April 30, 2026 DBV Technologies Reports First Quarter 2026 Financial Results Reported cash and cash equivalents of $229 million as of March 31, 2026 —providing funding into the...
DBV Technologies publie ses résultats financiers du 1er trimestre 2026
Châtillon, France, 30 avril 2026 DBV Technologies publie ses résultats financiers du 1er trimestre 2026 Trésorerie et équivalents de trésorerie de 229 millions de dollars au 31 mars 2026, p...
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
European equities traded in the US as American depositary receipts were tracking higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
DBV Technologies GAAP EPS of -$1.05
* DBV Technologies press release [https://seekingalpha.com/pr/20453416-dbv-technologies-reports-full-year-2025-financial-results-and-business-update] (DBVT [https://seekingalpha.com/symbol/DBVT]): F...
Get DBV Technologies fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
